34
17. 6. 2022.
A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis
Neuropathological studies have shown that multiple sclerosis (MS) lesions are heterogeneous in terms of myelin/axon damage and repair as well as iron content. However, it remains a challenge to identify specific chronic lesion types, especially remyelinated lesions, in vivo in patients with MS.